Jacqueline E. Shea
2023
In 2023, Jacqueline E. Shea earned a total compensation of $2.4M as President and Chief Executive Officer at Inovio Pharmaceuticals, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $371,280 |
|---|---|
| Option Awards | $812,999 |
| Salary | $750,615 |
| Stock Awards | $491,873 |
| Other | $12,141 |
| Total | $2,438,908 |
Shea received $813K in option awards, accounting for 33% of the total pay in 2023.
Shea also received $371.3K in non-equity incentive plan, $750.6K in salary, $491.9K in stock awards and $12.1K in other compensation.
Rankings
In 2023, Jacqueline E. Shea's compensation ranked 410th out of 3,006 executives tracked by ExecPay. In other words, Shea earned more than 86.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 410 out of 3,006 | 86th |
Division Manufacturing | 232 out of 1,650 | 86th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 24 out of 256 | 91st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 19 out of 188 | 90th |
Industry Surgical and Medical Instruments and Apparatus | 18 out of 144 | 88th |
Source: SEC filing on April 11, 2024.
Shea's colleagues
We found two more compensation records of executives who worked with Jacqueline E. Shea at Inovio Pharmaceuticals in 2023.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021